Longliv Ventures

ApoWiser operates a digital platform designed to assist consumers in navigating the complexities of Over-The-Counter (OTC) pharmaceuticals, including medications, vitamins, minerals, and supplements. By leveraging an advanced Business Intelligence system, ApoWiser provides personalized, science-based recommendations tailored to individual factors such as age and health conditions. This service helps consumers identify suitable OTC and VMS products while also addressing potential allergies and sensitivities. The platform seamlessly integrates with major health providers and pharmacy chains, enhancing user engagement and significantly improving conversion rates. As the demand for digital self-care solutions rises, ApoWiser is positioned to redefine how consumers approach personalized healthcare, offering a streamlined and informative shopping experience.

AceAge is a healthcare technology company focused on enhancing health outcomes for aging individuals through innovative products. The company's flagship product, Karie, is a home health appliance designed to help users manage their medication routines effectively. Karie organizes, schedules, and dispenses pills with one-button control, addressing the critical issue of medication nonadherence, which costs the U.S. healthcare system approximately $290 billion annually. By automating daily medication routines, Karie minimizes human error and supports greater patient autonomy, ultimately improving compliance with prescribed medical directions. The device utilizes common multi-dose pouch packaging that can be pre-set by pharmacists, ensuring that doses are delivered and monitored accurately. Through its user-friendly design, AceAge aims to enhance patient health while reducing the necessity for emergency care visits and assisted living admissions.

Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.

DayTwo Ltd. is a precision nutrition company headquartered in Tel Aviv-Yafo, Israel, that focuses on leveraging gut microbiome insights to improve health outcomes and prevent diseases such as diabetes, prediabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Founded in 2015, DayTwo employs microbiome sequencing to create personalized dietary recommendations, known as Food Prescriptions™, tailored to individual responses to food. This approach helps manage blood sugar levels, enhance energy, control hunger, and promote weight loss. DayTwo delivers its services through a digital platform and mobile application, enabling users to track their progress and communicate with certified diabetes care specialists and registered dietitians. By emphasizing personalized nutrition based on scientific research, DayTwo aims to empower patients to lead healthier lives through informed dietary choices.

DayTwo Ltd. is a precision nutrition company headquartered in Tel Aviv-Yafo, Israel, that focuses on leveraging gut microbiome insights to improve health outcomes and prevent diseases such as diabetes, prediabetes, obesity, and non-alcoholic fatty liver disease (NAFLD). Founded in 2015, DayTwo employs microbiome sequencing to create personalized dietary recommendations, known as Food Prescriptions™, tailored to individual responses to food. This approach helps manage blood sugar levels, enhance energy, control hunger, and promote weight loss. DayTwo delivers its services through a digital platform and mobile application, enabling users to track their progress and communicate with certified diabetes care specialists and registered dietitians. By emphasizing personalized nutrition based on scientific research, DayTwo aims to empower patients to lead healthier lives through informed dietary choices.

Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, focused on advancing blood diagnostics through the integration of machine vision and artificial intelligence. The company has developed a platform that utilizes digital fluorescent microscopy and computer vision algorithms to diagnose various blood diseases. Its flagship product, Parasight, is designed for malaria detection and has been used in nearly one million tests across 24 countries, although it is not available for sale in the United States. Additionally, Sight Diagnostics has introduced the Sight OLO, a blood analyzer that requires only two drops of blood from a finger prick or venous sample to deliver lab-grade Complete Blood Count results within minutes. With a presence in the UK, the US, and Israel, Sight Diagnostics is expanding its commercial footprint across five continents, aiming to enhance healthcare through fast and accurate blood testing solutions.